Second Opinion: Correcting Big Pharma’s Claims On The Rebate Rule

07-12-2019 Blog Posts

America’s seniors and taxpayers received a huge win today when the administration made the right call to withdraw a proposal, known as the Rebate Rule, from the Department of Health and Human Services (HHS). The Campaign for Sustainable Rx Pricing (CSRxP) was a leading voice raising concerns with the proposed rule, including, among others, its […]

CSRxP: STRONGER Patents Act Could Further Enable Big Pharma’s Patent Abuse

07-10-2019 Blog Posts

Proposed Bill Would Undermine Fair and Efficient Review Process For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today on the introduction of The Support Technology & Research for Our Nation’s Growth and Economic Resilience (STRONGER) Patents Act of 2019. “Inter partes reviews […]

THEY SAID IT! Senators on Aging Panel Pledge Bipartisan Action To Lower Drug Prices & Hold Big Pharma Accountable

06-20-2019 Blog Posts

For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]   Washington, D.C. – The U.S. Senate Special Committee on Aging held its third hearing on the “Complex Web of Prescription Drug Prices” on Wednesday.  Senators from both sides of the aisle called for action to lower drug prices for not only seniors, but all patients, and […]

Q1 Earnings Show Big Pharma Booming While American Patients Struggle

05-1-2019 Blog Posts

Largest Drug Makers Beat Profit Forecasts While Continuing To Price Gouge Patients For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday following earnings announcements from ten Big Pharma giants that showed they all surpassed profit forecasts for the first quarter of 2019. […]

Big Pharma Earnings Watch

05-1-2019 Blog Posts

GSK Completes The Sweep: Joins Fellow Drug Maker Giants In Beating Q1 Profit Forecasts One more pharmaceutical giant reported its first-quarter earnings today and surpassed expectations.  The forecast-topping announcement completed a sweep for Big Pharma.  Ten of the largest drug makers have now all bested earnings expectations for the first quarter of 2019. GlaxoSmithKline (GSK), […]

Q1 EARNINGS SHOW BIG PHARMA BOOMING WHILE AMERICAN PATIENTS STRUGGLE

05-1-2019 Blog Posts

Largest Drug Makers Beat Profit Forecasts While Continuing To Price Gouge Patients For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday following earnings announcements from ten Big Pharma giants that showed they all surpassed profit forecasts for the first quarter of 2019. […]

Big Pharma Earnings Watch: Three More Pharma Giants Top Earnings Forecasts, Raise Outlooks

04-30-2019 Blog Posts

Three more earnings reports from drug makers show Big Pharma is doing just fine as rising prices continue to hammer American patients. Today, Big Pharma giants Eli Lilly, Merck and Pfizer released their quarterly profits.  All three companies beat earnings forecasts. Despite a drop in revenue, Eli Lilly still beat profit expectations. Merck earned $10.81 […]

Big Pharma Earnings Watch

04-27-2019 Blog Posts

Big Pharma Flying High: Sanofi & AstraZeneca Beat First Quarter Profit Forecasts, Continue Industry Trend  Another day, another pair of price-gouging Big Pharma companies announcing they had surpassed profit expectations for the first quarter of 2019. Drug makers AstraZeneca and Sanofi both announced this past Friday their earnings beat expectations for first quarter 2019.  The […]

Big Pharma Earnings Watch: Bristol-Myers Squibb

04-26-2019 Blog Posts

Trend Emerges: Bristol-Myers Squibb Joins Big Pharma Colleagues Beating First Quarter Profit Forecasts Another Big Pharma company announced higher than expected earnings – the latest in a growing trend indicating the industry continues to rake in profits, while facing greater scrutiny for rising prescription drug prices. Bristol-Myers Squibb reported better-than-expected earnings in the first quarter […]

Big Pharma Earnings Watch: AbbVie

04-26-2019 Blog Posts

AbbVie Beats Forecast But Dips In Revenue In Demonstration That Competition Lowers Prices AbbVie released its first quarter earnings and beat projections and raised its profit outlook.  CEO Richard Gonzalez said that the company was off to an “excellent start” for the year – the latest indication Big Pharma continues to thrive, while price-gouging American […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.